文献速递冠心病

SCOT-HEART研究:冠状动脉斑块特征与不良结局相关

Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

该研究为SCOT-HEART试验的事后分析,对1769例疑似冠心病患者行冠状动脉CT血管造影并随访5年,评估不良斑块特征、阻塞性病变及钙化的预后意义。结果显示,不良斑块特征和总钙化斑块负荷与冠心病死亡或非致死性心肌梗死风险增加相关,但校正冠状动脉钙化评分后关联不再独立。

要点

  • 不良斑块特征(正性重构或低密度斑块)与冠心病死亡或非致死性心梗风险增加约3倍相关。
  • 阻塞性病变与冠心病死亡或非致死性心梗风险增加约2倍相关。
  • 阻塞性病变合并不良斑块特征者事件率最高,但关联不独立于冠状动脉钙化评分。

核心结论

  • 不良冠状动脉斑块特征和总体钙化斑块负荷增加冠心病死亡或非致死性心肌梗死风险。
  • 不良斑块特征和阻塞性病变的预后关联不独立于冠状动脉钙化评分。

研究设计与样本

  • SCOT-HEART试验事后分析,纳入1769例疑似冠心病患者,行冠状动脉CT血管造影评估15个冠状动脉节段,随访5年。

主要发现

  • 608例(34%)患者存在至少1个不良斑块特征。
  • 不良斑块特征患者冠心病死亡或非致死性心梗发生率4.1%(25/608) vs 1.4%(16/1161),HR 3.01(95%CI 1.61-5.63),p=0.001。
  • 阻塞性病变患者事件率4.9%(22/452) vs 2.4%(16/671),HR 1.99(95%CI 1.05-3.79),p=0.036。
  • 阻塞性病变合并不良斑块特征者较正常冠状动脉者事件风险增加10倍,HR 11.50(95%CI 3.39-39.04),p<0.001。

临床怎么用

  • 冠状动脉CT血管造影识别的不良斑块特征和阻塞性病变可帮助评估疑似冠心病患者的风险。
  • 冠状动脉钙化评分可能解释部分斑块特征相关的风险,需综合评估斑块负荷。

局限性

  • 关联不独立于冠状动脉钙化评分,提示斑块特征预后价值受斑块负荷影响。
  • 事后分析设计可能影响因果推断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Unlike most noninvasive imaging modalities, coronary computed tomography angiography can characterize subtypes of atherosclerotic plaque. OBJECTIVES: The purpose of this study was to investigate the prognostic implications of adverse coronary plaque characteristics in patients with suspected coronary artery disease. METHODS: In this SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) post hoc analysis, the presence of adverse plaque (positive remodeling or low attenuation plaque), obstructive disease, and coronary artery calcification within 15 coronary segments was assessed on coronary computed tomography angiography of 1,769 patients who were followed-up for 5 years. RESULTS: Among study participants (mean age 58 ± 10 years; 56% male), 608 (34%) patients had 1 or more adverse plaque features. Coronary heart disease death or nonfatal myocardial infarction was 3 times more frequent in patients with adverse plaque (n = 25 of 608 [4.1%] vs. n = 16 of 1,161 [1.4%]; p < 0.001; hazard ratio [HR]: 3.01; 95% confidence interval (CI): 1.61 to 5.63; p = 0.001) and was twice as frequent in those with obstructive disease (n = 22 of 452 [4.9%] vs. n = 16 of 671 [2.4%]; p = 0.024; HR: 1.99; 95% CI: 1.05 to 3.79; p = 0.036). Patients with both obstructive disease and adverse plaque had the highest event rate, with a 10-fold increase in coronary heart disease death or nonfatal myocardial infarction compared with patients with normal coronary arteries (HR: 11.50; 95% CI: 3.39 to 39.04; p < 0.001). However, these associations were not independent of coronary artery calcium score, a surrogate measure of coronary plaque burden. CONCLUSIONS: Adverse coronary plaque characteristics and overall calcified plaque burden confer an increased risk of coronary heart disease death or nonfatal myocardial infarction. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Williams MC, Moss AJ, Dweck M, et al. Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study. J Am Coll Cardiol. 2019. PMID: 30678759. doi:10.1016/j.jacc.2018.10.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。